To further capitalize on the concept of HF medication use in the absence of other (non-HF) indications, we also incorporated the use of neuro-hormonal blockers (renin-angiotensin inhibitors and beta blockers) in the absence of hypertension to identify and exclude participants from our HF-free cohort. This evidence concerns the gene REN and Hypertension.